NMC Health plc
NMMCF · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Revenue | $2,057 | $1,603 | $1,221 | $881 |
| % Growth | 28.3% | 31.3% | 38.6% | – |
| Cost of Goods Sold | $1,216 | $968 | $753 | $576 |
| Gross Profit | $841 | $635 | $468 | $305 |
| % Margin | 40.9% | 39.6% | 38.3% | 34.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $443 | $335 | $268 | $191 |
| SG&A Expenses | $443 | $335 | $268 | $191 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $454 | $353 | $277 | $190 |
| Operating Income | $380 | $274 | $184 | $111 |
| % Margin | 18.5% | 17.1% | 15.1% | 12.6% |
| Other Income/Exp. Net | -$123 | -$63 | -$33 | -$26 |
| Pre-Tax Income | $257 | $210 | $152 | $85 |
| Tax Expense | $5 | $1 | $0 | -$0 |
| Net Income | $249 | $186 | $133 | $82 |
| % Margin | 12.1% | 11.6% | 10.9% | 9.3% |
| EPS | 1.2 | 0.91 | 0.71 | 0.44 |
| % Growth | 31.9% | 28.2% | 61.4% | – |
| EPS Diluted | 1.19 | 0.9 | 0.71 | 0.44 |
| Weighted Avg Shares Out | 208 | 204 | 187 | 186 |
| Weighted Avg Shares Out Dil | 209 | 206 | 188 | 186 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $2 | $1 | $1 |
| Interest Expense | $112 | $60 | $32 | $20 |
| Depreciation & Amortization | $100 | $71 | $56 | $35 |
| EBITDA | $469 | $334 | $239 | $139 |
| % Margin | 22.8% | 20.9% | 19.6% | 15.8% |